ArticleTheranostics2026

One-step knock-in CAR constructs in human NK cells enable scalable, TGFβ1-resistant immunotherapy for solid tumors.

Su-Min Yee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.